company background image
950 logo

Lee's Pharmaceutical Holdings SEHK:950 Stock Report

Last Price

HK$1.16

Market Cap

HK$683.0m

7D

2.7%

1Y

-21.1%

Updated

13 Jul, 2024

Data

Company Financials +

Lee's Pharmaceutical Holdings Limited

SEHK:950 Stock Report

Market Cap: HK$683.0m

950 Stock Overview

An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.

950 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Lee's Pharmaceutical Holdings Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lee's Pharmaceutical Holdings
Historical stock prices
Current Share PriceHK$1.16
52 Week HighHK$1.75
52 Week LowHK$1.00
Beta0.92
11 Month Change-2.52%
3 Month Change-1.69%
1 Year Change-21.09%
33 Year Change-74.56%
5 Year Change-77.61%
Change since IPO123.08%

Recent News & Updates

Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

May 21
Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

Recent updates

Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

May 21
Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Dec 20
Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

May 21
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Apr 02
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Aug 29
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Apr 05
Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Mar 17
Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

Feb 22
Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 29
What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

Jan 12
What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

Have Insiders Sold Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Recently?

Dec 22
Have Insiders Sold Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Recently?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Lee's Pharmaceutical Holdings Limited (HKG:950)

Dec 08
Don't Ignore The Fact That This Insider Just Sold Some Shares In Lee's Pharmaceutical Holdings Limited (HKG:950)

Is Lee's Pharmaceutical Holdings Limited's (HKG:950) Recent Price Movement Underpinned By Its Weak Fundamentals?

Dec 01
Is Lee's Pharmaceutical Holdings Limited's (HKG:950) Recent Price Movement Underpinned By Its Weak Fundamentals?

Is Lee's Pharmaceutical Holdings Limited (HKG:950) A Strong Dividend Stock?

Nov 18
Is Lee's Pharmaceutical Holdings Limited (HKG:950) A Strong Dividend Stock?

Shareholder Returns

950HK PharmaceuticalsHK Market
7D2.7%-0.5%0.5%
1Y-21.1%-5.2%1.8%

Return vs Industry: 950 underperformed the Hong Kong Pharmaceuticals industry which returned -5.2% over the past year.

Return vs Market: 950 underperformed the Hong Kong Market which returned 1.8% over the past year.

Price Volatility

Is 950's price volatile compared to industry and market?
950 volatility
950 Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement6.9%
10% most volatile stocks in HK Market14.7%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 950 has not had significant price volatility in the past 3 months.

Volatility Over Time: 950's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19941,057n/awww.leespharm.com

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. It focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates through Proprietary and Generic Products; and Licensed-In Products segments.

Lee's Pharmaceutical Holdings Limited Fundamentals Summary

How do Lee's Pharmaceutical Holdings's earnings and revenue compare to its market cap?
950 fundamental statistics
Market capHK$683.05m
Earnings (TTM)HK$16.70m
Revenue (TTM)HK$1.05b

40.9x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
950 income statement (TTM)
RevenueHK$1.05b
Cost of RevenueHK$501.72m
Gross ProfitHK$551.31m
Other ExpensesHK$534.61m
EarningsHK$16.70m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.028
Gross Margin52.35%
Net Profit Margin1.59%
Debt/Equity Ratio9.8%

How did 950 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

63%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.